Back to search
FDAFDA · Food and drugs·Recall number Z-1680-2018

IMMULITE ¿ /IMMULITE 1000 ¿ Gastrin

Published May 16, 2018 · Recall initiated: January 2, 2018

Summary

FDA records medical device Class II recall Z-1680-2018, published May 16, 2018 and initiated January 2, 2018. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Gastrin, Gastrin (IMMULITE/IMMULITE 1000, LKGA1), (IMMULITE 2000/IMMULITE 2000 XPi, LKGA2) Lot codes: Gastrin Lot # 0345 0346 0347. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Nationwide and Canada, Mexico, and Thailand
Lot
Gastrin, Gastrin (IMMULITE/IMMULITE 1000, LKGA1), (IMMULITE 2000/IMMULITE 2000 XPi, LKGA2) Lot codes: Gastrin Lot # 0345 0346 0347
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IMMULITE ¿ /IMMULITE 1000 ¿ Gastrin recalled?

Yes. FDA published recall Z-1680-2018 on May 16, 2018. Reported hazard: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter